Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewed
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma
Katy L. Swancutt, Eslam A. Elghonaimy, James H. Nicholson…·Todd Anthony Aguilera
This study evaluates carbon ion therapy's effectiveness in pancreatic ductal adenocarcinoma, finding that immune stromal components reduce its efficacy in vivo compared to in vitro results.
4 citations